1798349-30-0
1798349-30-0
Chemical Structure
Biological Activity: AMG-167 is an anti-cancer monoclonal antibody targeting sclerostin. AMG-167 can be studied in research for osteoporosis[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AMG-167 | AMG-167 is an anti-cancer monoclonal antibody targeting sclerostin. AMG-167 can be studied in research for osteoporosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. MacNabb, C., et al., (2016). Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges. Journal of osteoporosis, 2016, 6217286. [Content Brief]
- [2]. Dede, A. D., et al., (2017). Investigational anabolic agents for the treatment of osteoporosis: an update on recent developments. Expert opinion on investigational drugs, 26(10), 1137–1144. [Content Brief]
Keywords
